{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:30:07Z","timestamp":1772166607302,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00871-1","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T15:05:48Z","timestamp":1765033548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genome-wide methylation profiles of primary and matched distant metastasis: insights from the Dutch Early-Stage melanoma (D-ESMEL) study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2556-2125","authenticated-orcid":false,"given":"Jasper","family":"Ouwerkerk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5857-1792","authenticated-orcid":false,"given":"Thamila","family":"Kerkour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9810-5780","authenticated-orcid":false,"given":"Antien","family":"Mooyaart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7157-6341","authenticated-orcid":false,"given":"Catherine","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3377-2897","authenticated-orcid":false,"given":"Ruben","family":"Boers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Boers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Gribnau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8578-901X","authenticated-orcid":false,"given":"Marlies","family":"Wakkee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5697-1602","authenticated-orcid":false,"given":"Yunlei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8922-6791","authenticated-orcid":false,"given":"Loes","family":"Hollestein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"871_CR1","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.3390\/cancers13174431","volume":"13","author":"C Zhou","year":"2021","unstructured":"Zhou C, Louwman M, Wakkee M, van der Veldt A, Gr\u00fcnhagen D, Verhoef C, et al. Primary melanoma characteristics of metastatic disease: A nationwide cancer registry study. Cancers (Basel). 2021;13:4431. https:\/\/doi.org\/10.3390\/cancers13174431.","journal-title":"Cancers (Basel)"},{"key":"871_CR2","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/cam4.1152","volume":"6","author":"EAL Enninga","year":"2017","unstructured":"Enninga EAL, Moser JC, Weaver AL, Markovic SN, Brewer JD, Leontovich AA, et al. Survival of cutaneous melanoma based on sex, age, and stage in the united States, 1992\u20132011. Cancer Med. 2017;6:2203\u201312. https:\/\/doi.org\/10.1002\/cam4.1152.","journal-title":"Cancer Med"},{"key":"871_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/bjd.19015","volume":"184","author":"K Isaksson","year":"2021","unstructured":"Isaksson K, Mikiver R, Eriksson H, Lapins J, Nielsen K, Ingvar C, et al. Survival in 31 670 patients with thin melanomas: a Swedish population-based study*. Br J Dermatol. 2021;184:60\u20137. https:\/\/doi.org\/10.1111\/bjd.19015.","journal-title":"Br J Dermatol"},{"key":"871_CR4","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/S0140-6736(22)00562-1","volume":"399","author":"JJ Luke","year":"2022","unstructured":"Luke JJ, Rutkowski P, Queirolo P, Del Vecchio M, Mackiewicz J, Chiarion-Sileni V, et al. Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial. Lancet. 2022;399:1718\u201329. https:\/\/doi.org\/10.1016\/S0140-6736(22)00562-1.","journal-title":"Lancet"},{"key":"871_CR5","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1038\/s41591-023-02583-2","volume":"29","author":"JM Kirkwood","year":"2023","unstructured":"Kirkwood JM, Del Vecchio M, Weber J, Hoeller C, Grob J-J, Mohr P, et al. Adjuvant nivolumab in resected stage IIB\/C melanoma: primary results from the randomized, phase 3 checkmate 76K trial. Nat Med. 2023;29:2835\u201343. https:\/\/doi.org\/10.1038\/s41591-023-02583-2.","journal-title":"Nat Med"},{"key":"871_CR6","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00262-020-02777-4","volume":"70","author":"S Fietz","year":"2021","unstructured":"Fietz S, Zarbl R, Niebel D, Posch C, Brossart P, Gielen GH, et al. CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab). Cancer Immunol Immunother. 2021;70:1781\u20138. https:\/\/doi.org\/10.1007\/s00262-020-02777-4.","journal-title":"Cancer Immunol Immunother"},{"key":"871_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/hmg\/ddt420","volume":"23","author":"DM Marzese","year":"2014","unstructured":"Marzese DM, Scolyer RA, Huynh JL, Huang SK, Hirose H, Chong KK, et al. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum Mol Genet. 2014;23:226\u201338. https:\/\/doi.org\/10.1093\/hmg\/ddt420.","journal-title":"Hum Mol Genet"},{"key":"871_CR8","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"R Akbani","year":"2015","unstructured":"Akbani R, Akdemir KC, Aksoy BA, Albert M, Ally A, Amin SB, et al. Genomic classification of cutaneous melanoma. Cell. 2015;161:1681\u201396. https:\/\/doi.org\/10.1016\/j.cell.2015.05.044.","journal-title":"Cell"},{"key":"871_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12916-017-0851-3","volume":"15","author":"J Wouters","year":"2017","unstructured":"Wouters J, Vizoso M, Martinez-Cardus A, Carmona FJ, Govaere O, Laguna T, et al. Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma. BMC Med. 2017;15:101. https:\/\/doi.org\/10.1186\/s12916-017-0851-3.","journal-title":"BMC Med"},{"key":"871_CR10","doi-asserted-by":"publisher","DOI":"10.1200\/PO-24-00375","author":"K Conway","year":"2024","unstructured":"Conway K, Edmiston SN, Vondras A, Reiner A, Corcoran DL, Shen R, et al. DNA methylation classes of stage II and III primary melanomas and their clinical and prognostic significance. JCO Precis Oncol. 2024. https:\/\/doi.org\/10.1200\/PO-24-00375.","journal-title":"JCO Precis Oncol"},{"key":"871_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1101\/gr.222885.117","volume":"28","author":"R Boers","year":"2018","unstructured":"Boers R, Boers J, De Hoon B, Kockx C, Ozgur Z, Molijn A, et al. Genome-wide DNA methylation profiling using the methylation-dependent restriction enzyme LpnPI. Genome Res. 2018;28:88\u201399. https:\/\/doi.org\/10.1101\/gr.222885.117.","journal-title":"Genome Res"},{"key":"871_CR12","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.3390\/cancers15194784","volume":"15","author":"S Fu","year":"2023","unstructured":"Fu S, Deger T, Boers RG, Boers JB, Doukas M, Gribnau J, et al. Hypermethylation of DNA methylation markers in Non-Cirrhotic hepatocellular carcinoma. Cancers (Basel). 2023;15:4784. https:\/\/doi.org\/10.3390\/cancers15194784.","journal-title":"Cancers (Basel)"},{"key":"871_CR13","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/cancers15051374","volume":"15","author":"MK Bos","year":"2023","unstructured":"Bos MK, Verhoeff SR, Oosting SF, van Menke-van der Houven WC, Boers RG, Boers JB, et al. Methylated cell-Free DNA sequencing (MeD-seq) of LpnPI digested fragments to identify early progression in metastatic renal cell carcinoma patients on watchful waiting. Cancers (Basel). 2023;15:1374. https:\/\/doi.org\/10.3390\/cancers15051374.","journal-title":"Cancers (Basel)"},{"key":"871_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41598-021-03964-8","volume":"12","author":"KN Smit","year":"2022","unstructured":"Smit KN, Boers R, Vaarwater J, Boers J, Brands T, Mensink H, et al. Genome-wide aberrant methylation in primary metastatic UM and their matched metastases. Sci Rep. 2022;12:42. https:\/\/doi.org\/10.1038\/s41598-021-03964-8.","journal-title":"Sci Rep"},{"key":"871_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10654-024-01188-4","volume":"40","author":"C Zhou","year":"2025","unstructured":"Zhou C, Mooyaart AL, Kerkour T, Louwman MWJ, Wakkee M, Li Y, et al. The Dutch Early-Stage melanoma (D-ESMEL) study: a discovery set and validation cohort to predict the absolute risk of distant metastases in stage I\/II cutaneous melanoma. Eur J Epidemiol. 2025;40:27\u201342. https:\/\/doi.org\/10.1007\/s10654-024-01188-4.","journal-title":"Eur J Epidemiol"},{"key":"871_CR16","doi-asserted-by":"publisher","unstructured":"Boers J, Boers R, Sakoltchik J, Dasgupta S, Martens L, Tadema KCD et al. DNA methylation database for gynecological cancer detection, classification and assay development. 2024. https:\/\/doi.org\/10.1101\/2024.07.01.601485","DOI":"10.1101\/2024.07.01.601485"},{"key":"871_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/path.3970","volume":"227","author":"W Quint","year":"2012","unstructured":"Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, et al. One virus, one lesion\u2014individual components of CIN lesions contain a specific HPV type. J Pathol. 2012;227:62\u201371. https:\/\/doi.org\/10.1002\/path.3970.","journal-title":"J Pathol"},{"key":"871_CR18","doi-asserted-by":"publisher","first-page":"D1243","DOI":"10.1093\/nar\/gkae974","volume":"53","author":"G Perez","year":"2025","unstructured":"Perez G, Barber GP, Benet-Pages A, Casper J, Clawson H, Diekhans M, et al. The UCSC genome browser database: 2025 update. Nucleic Acids Res. 2025;53:D1243\u20139. https:\/\/doi.org\/10.1093\/nar\/gkae974.","journal-title":"Nucleic Acids Res"},{"key":"871_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/CAD.0000000000000046","volume":"25","author":"J Wang","year":"2014","unstructured":"Wang J, Ma D, Li Y, Yang Y, Hu X, Zhang W, et al. Targeted delivery of CYP2E1 Recombinant adenovirus to malignant melanoma by bone marrow-derived mesenchymal stem cells as vehicles. Anticancer Drugs. 2014;25:303\u201314. https:\/\/doi.org\/10.1097\/CAD.0000000000000046.","journal-title":"Anticancer Drugs"},{"key":"871_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10048-011-0308-3","volume":"13","author":"O Kaut","year":"2012","unstructured":"Kaut O, Schmitt I, W\u00fcllner U. Genome-scale methylation analysis of parkinson\u2019s disease patients\u2019 brains reveals DNA hypomethylation and increased mRNA expression of cytochrome P450 2E1. Neurogenetics. 2012;13:87\u201391. https:\/\/doi.org\/10.1007\/s10048-011-0308-3.","journal-title":"Neurogenetics"},{"key":"871_CR21","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma staging: Evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472\u201392. https:\/\/doi.org\/10.3322\/caac.21409.","journal-title":"CA Cancer J Clin"},{"key":"871_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.15252\/embj.201591973","volume":"35","author":"CA Sengelaub","year":"2016","unstructured":"Sengelaub CA, Navrazhina K, Ross JB, Halberg N, Tavazoie SF. PTPRN2 and PLC\u03b21 promote metastatic breast cancer cell migration through PI(4,5)P2-dependent actin remodeling. EMBO J. 2016;35:62\u201376. https:\/\/doi.org\/10.15252\/embj.201591973.","journal-title":"EMBO J"},{"key":"871_CR23","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/ng.3861","volume":"49","author":"ME Feigin","year":"2017","unstructured":"Feigin ME, Garvin T, Bailey P, Waddell N, Chang DK, Kelley DR, et al. Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma. Nat Genet. 2017;49:825\u201333. https:\/\/doi.org\/10.1038\/ng.3861.","journal-title":"Nat Genet"},{"key":"871_CR24","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1002\/cam4.4078","volume":"10","author":"J Yin","year":"2021","unstructured":"Yin J, Guo Y. HOXD13 promotes the malignant progression of colon cancer by upregulating PTPRN2. Cancer Med. 2021;10:5524\u201333. https:\/\/doi.org\/10.1002\/cam4.4078.","journal-title":"Cancer Med"},{"key":"871_CR25","doi-asserted-by":"publisher","unstructured":"Gundamaraju R, Lu W, Manikam R. CHCHD2: the power house\u2019s potential prognostic factor for cancer? Front Cell Dev Biol. 2021;8. https:\/\/doi.org\/10.3389\/fcell.2020.620816.","DOI":"10.3389\/fcell.2020.620816"},{"key":"871_CR26","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1093\/nar\/gkn504","volume":"36","author":"N Liu","year":"2008","unstructured":"Liu N, Wang L, Li X, Yang Q, Liu X, Zhang J, et al. N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis. Nucleic Acids Res. 2008;36:5335\u201349. https:\/\/doi.org\/10.1093\/nar\/gkn504.","journal-title":"Nucleic Acids Res"},{"key":"871_CR27","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/emm.2007.77","volume":"39","author":"S-C Choi","year":"2007","unstructured":"Choi S-C, Yoon SR, Park YP, Song EY, Kim JW, Kim WH, et al. Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death. Exp Mol Med. 2007;39:705\u201314. https:\/\/doi.org\/10.1038\/emm.2007.77.","journal-title":"Exp Mol Med"},{"key":"871_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10620-012-2393-z","volume":"58","author":"X Chang","year":"2013","unstructured":"Chang X, Li Z, Ma J, Deng P, Zhang S, Zhi Y, et al. DNA methylation of NDRG2 in gastric cancer and its clinical significance. Dig Dis Sci. 2013;58:715\u201323. https:\/\/doi.org\/10.1007\/s10620-012-2393-z.","journal-title":"Dig Dis Sci"},{"key":"871_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1755-148X.2010.00678.x","volume":"23","author":"A Saldana-Caboverde","year":"2010","unstructured":"Saldana-Caboverde A, Kos L. Roles of endothelin signaling in melanocyte development and melanoma. Pigment Cell Melanoma Res. 2010;23:160\u201370. https:\/\/doi.org\/10.1111\/j.1755-148X.2010.00678.x.","journal-title":"Pigment Cell Melanoma Res"},{"key":"871_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.22088\/cjim.8.4.228","volume":"8","author":"E Saburi","year":"2017","unstructured":"Saburi E, Saburi A, Ghanei M. Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside. Caspian J Intern Med. 2017;8:228\u201338. https:\/\/doi.org\/10.22088\/cjim.8.4.228.","journal-title":"Caspian J Intern Med"},{"key":"871_CR31","doi-asserted-by":"publisher","unstructured":"Danahy L, Long C, Hofmann TJ, Tara Z, Mark J, Roizen JD. Dietary vitamin D is a novel modulator of tumor engraftment through regulation of GC protein abundance. 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-3911213\/v1","DOI":"10.21203\/rs.3.rs-3911213\/v1"},{"key":"871_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13148-022-01382-9","volume":"14","author":"Q Wang","year":"2022","unstructured":"Wang Q, Xiong F, Wu G, Liu W, Chen J, Wang B, et al. Gene body methylation in cancer: molecular mechanisms and clinical applications. Clin Epigenetics. 2022;14:154. https:\/\/doi.org\/10.1186\/s13148-022-01382-9.","journal-title":"Clin Epigenetics"},{"key":"871_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/exd.14677","volume":"32","author":"L Ni","year":"2023","unstructured":"Ni L, Li P, Li M, Huang S, Dang N. SERPINB8 and Furin regulate ITGAX expression and affect the proliferation and invasion of melanoma cells. Exp Dermatol. 2023;32:24\u20139. https:\/\/doi.org\/10.1111\/exd.14677.","journal-title":"Exp Dermatol"},{"key":"871_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/1751-2980.12758","volume":"20","author":"DF Li","year":"2019","unstructured":"Li DF, Wang NN, Chang X, Wang SL, Wang LS, Yao J, et al. Bioinformatics analysis suggests that COL4A1 May play an important role in gastric carcinoma recurrence. J Dig Dis. 2019;20:391\u2013400. https:\/\/doi.org\/10.1111\/1751-2980.12758.","journal-title":"J Dig Dis"},{"key":"871_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/hed.28120","author":"K Wei","year":"2025","unstructured":"Wei K, Hill BL, Thompson JC, Miller ZA, Mueller A, Lee RJ, et al. Bitter taste receptor agonists induce apoptosis in papillary thyroid cancer. Head Neck. 2025. https:\/\/doi.org\/10.1002\/hed.28120.","journal-title":"Head Neck"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00871-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00871-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00871-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:05:09Z","timestamp":1768341909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-025-00871-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00871-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7642695\/v1","asserted-by":"object"}]},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The use of leftover diagnostic tissue samples for scientific research is based on the \u2018no objection\u2019 principle, as outlined in the Code of Conduct for Health Research by the Committee on Regulation of Health Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest or financial interests except for RB, JB and JG, who report being shareholder in Methylomics B.V., a commercial company that applies MeD-seq to develop methylation markers for cancer staging.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}